Resmed Inc. Live Share Price Today, Share Analysis and Chart
801.7K XNYS Volume
XNYS 19 Mar, 2025 5:30 PM (EDT)
Resmed Inc. Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Resmed Inc. Stock Price Analysis
Day Price Range | 222 (LTP) 220.4224 LowHigh |
Week Price Range | 222 (LTP) 217.5227 LowHigh |
Month Price Range | 222 (LTP) 217.5243.4 LowHigh |
52 Week Price Range | 222 (LTP) 172.2263 LowHigh |
Resmed Inc. Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Resmed Inc.'s Revenue was higher than average estimate 2 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 31.5% in FY25
Consensus Recommendation
18 ANALYST Recommendations
BUY
The consensus recommendation from 18 analysts for Resmed Inc. is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Resmed Inc. Stock Analysis
Resmed Inc. stock analysis with key metrics, changes, and trends.
Resmed Inc. Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $4,685.3 M | 10.95% | positive |
| |
Annual Net Profit | $1,020.95 M | 13.75% | positive |
| |
Price to Earning Ratio | 26.12 | - | positive |
| |
Stock Price | $222.05 | 16.28% | positive |
| |
Quarterly Revenue | $1,282.09 M | 10.26% | positive |
| |
Quarterly Net profit | $344.62 M | 65.05% | positive |
| |
Debt to Equity Ratio | 0.18 | - | positive |
| |
Return on Equity(ROE) | 22.70 % | 22.7% | positive |
| |
Mutual Fund Holding | 47.98 % | 0.07% | positive |
| |
Promoter Share Holding | 0.57 % | -0.01% | negative |
| |
Interest Coverage Ratio | 28.67 | - | positive |
| |
Institutional Holding | 61.37 % | 0% | neutral |
|
Loading data..
Resmed Inc. - Company Profile
What does Resmed Inc. do?

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Resmed Inc. Management structure
All Gross Remunerations are in USD